Aemetis Inc. (NASDAQ:AMTX) went down by -5.07% from its latest closing price compared to the recent 1-year high of $27.44. The company’s stock price has collected 10.02% of gains in the last five trading sessions. Press Release reported on 04/01/21 that Thinking about buying stock in Arbutus Biopharma, Aemetis, FuboTV, Rubius Therapeutics, or Lithium Americas Corp?
Is It Worth Investing in Aemetis Inc. (NASDAQ :AMTX) Right Now?
Plus, the 36-month beta value for AMTX is at -0.03. Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for Aemetis Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $33.00, which is $7.3 above the current price. AMTX currently public float of 19.62M and currently shorts hold a 3.47% ratio of that float. Today, the average trading volume of AMTX was 4.72M shares.
AMTX’s Market Performance
AMTX stocks went up by 10.02% for the week, with a monthly jump of 87.83% and a quarterly performance of 707.19%, while its annual performance rate touched 4474.92%. The volatility ratio for the week stands at 9.17% while the volatility levels for the past 30 days are set at 14.61% for Aemetis Inc.. The simple moving average for the period of the last 20 days is 15.53% for AMTX stocks with a simple moving average of 358.48% for the last 200 days.
Analysts’ Opinion of AMTX
Many brokerage firms have already submitted their reports for AMTX stocks, with Credit Suisse repeating the rating for AMTX by listing it as a “Outperform.” The predicted price for AMTX in the upcoming period, according to Credit Suisse is $35 based on the research report published on March 22nd of the current year 2021.
Truist, on the other hand, stated in their research note that they expect to see AMTX reach a price target of $35. The rating they have provided for AMTX stocks is “Buy” according to the report published on March 19th, 2021.
Stifel gave a rating of “Buy” to AMTX, setting the target price at $25 in the report published on March 09th of the current year.
AMTX Trading at 73.71% from the 50-Day Moving Average
After a stumble in the market that brought AMTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.99% of loss for the given period.
Volatility was left at 14.61%, however, over the last 30 days, the volatility rate increased by 9.17%, as shares surge +54.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +180.68% upper at present.
During the last 5 trading sessions, AMTX rose by +10.02%, which changed the moving average for the period of 200-days by +2,904.14% in comparison to the 20-day moving average, which settled at $21.82. In addition, Aemetis Inc. saw 891.97% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AMTX
Current profitability levels for the company are sitting at:
- -3.67 for the present operating margin
- +6.66 for the gross margin
The net margin for Aemetis Inc. stands at -22.14. The total capital return value is set at -8.18, while invested capital returns managed to touch -123.53. Equity return is now at value 21.20, with -31.00 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 1.93, with the company’s debt to enterprise value settled at 0.84. The receivables turnover for the company is 85.85 and the total asset turnover is 1.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.08.